Ertugliflozin
Composition
Single tablet of Ertugliflozin 5mg/ 15mg contain19.43 mg Ertugliflozin L-pyroglutamic acid equivalent to 5mg 15mg Ertugliflozin
Indications
It is indicated to control high blood sugar levels in adult patients with type 2 diabetes
Side effects
Mild to moderate side effects have been observed such as swelling of the face, little or no urination, blood in urine, vaginal discharge
Precautions
This drug is to be cautiously used in patients with ketoacidosis, lower limb amputation, renal disease in pregnancy, and lactation
Contraindications
Use of this drug is contraindicated in patients on dialysis, hypersensitivity
Dosage and administration
In adults the usual dose consists of a tablet of 5 mg to be given orally once in a day morning
Countries
We have also established roots and begun this new venture in other countries as well such as Libya, France, Oman, and Brazil
Available Forms
Manufacturing Services
Third Party Manufacturing Company WHO, GMP, EUGMP, USFDA, In India | Contract Manufacturing Organization (CMO) WHO, GMP, EUGMP, USFDA Services in India, Mumbai, Navi Mumbai| Contract Development and Manufacturing Organization (CDMO) WHO, GMP, EUGMP, USFDA - Services in India | Pharmaceutical Contract Manufacturing Company WHO, GMP, EUGMP, USFDA in Navi Mumbai, India | Top Pharmaceutical Product Exporters, Suppliers, Distributer WHO, GMP, EUGMP, USFDA in Mumbai